Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation. A ...

A new U.S. study found Anoro Elipta to be better than Bevespi Aerosphere or Stiolto Respimat at lowering the risk of disease flares in COPD.

HealthDay News — Implementation of a computerized multidisciplinary order set in the electronic health record improves the quality of physician pharmacologic prescribing for patients hospitalized for ...

Please provide your email address to receive an email when new articles are posted on . This study population represents patients with COPD and Th2 inflammation that clinicians treat daily. Included ...

In an observational study that began enrollment last month, researchers will determine if continuous, remote lung sound ...

No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both. HealthDay News — For patients with chronic obstructive pulmonary disease (COPD), ...

SAN DIEGO -- The beta-blocker bisoprolol did not improve exacerbations in chronic obstructive pulmonary disease (COPD) patients, a randomized clinical trial found. Exacerbations requiring antibiotics, ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit (ICU), lower eosinophil counts are associated with increased in-hospital ...

Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and wait ...